Supplementary Material - Efficacy and safety of oral JAK1 inhibitor upadacitinib monotherapy for papulopustular rosacea: A real-world study

Name: Supplementary Material - Efficacy and safety of oral JAK1 inhibitor upadacitinib monotherapy for papulopustular rosacea: A real-world study
Creator: Bingyang Xu
Published: 2025-04-04T14:04:32.927Z
Keywords: Dermatology, Rosacea

Xu, Bingyang; Qing, Yuxin; Wang, Yuanqin; Xu, Zining; Ye, Shuhong; Zhao, Bin; Hong, Sun; Wu, Na; Wu, Jiawen

doi:10.17632/kkygc7n7ms.1

Supplementary Material - Efficacy and safety of oral JAK1 inhibitor upadacitinib monotherapy for papulopustular rosacea: A real-world study

Published: 4 April 2025| Version 1 | DOI: 10.17632/kkygc7n7ms.1

Contributors:

Bingyang Xu, Yuxin Qing, Yuanqin Wang, Zining Xu, Shuhong Ye, Bin Zhao, Sun Hong, Na Wu, Jiawen Wu

Description

Supplementary Material for paper "Efficacy and safety of oral JAK1 inhibitor upadacitinib monotherapy for papulopustular rosacea: A real-world study"

Files

Institutions

Xi'an Jiaotong University Second Affiliated Hospital

Supplementary Material - Efficacy and safety of oral JAK1 inhibitor upadacitinib monotherapy for papulopustular rosacea: A real-world study

Description

Files

Institutions

Categories

Licence